BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puderbach M, Risse F, Biederer J, Ley-zaporozhan J, Ley S, Szabo G, Semmler W, Kauczor H. In vivo Gd-DTPA concentration for MR lung perfusion measurements: Assessment with computed tomography in a porcine model. Eur Radiol 2008;18:2102-7. [DOI: 10.1007/s00330-008-0974-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Washko GR, Parraga G. COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging. Eur Respir J 2018;52:1801570. [PMID: 30337445 DOI: 10.1183/13993003.01570-2018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
2 Salehi Ravesh M, Brix G, Laun FB, Kuder TA, Puderbach M, Ley-zaporozhan J, Ley S, Fieselmann A, Herrmann MF, Schranz W, Semmler W, Risse F. Quantification of pulmonary microcirculation by dynamic contrast-enhanced magnetic resonance imaging: Comparison of four regularization methods: Quantification of Pulmonary Microcirculation Using Different Regularization Methods. Magn Reson Med 2013;69:188-99. [DOI: 10.1002/mrm.24220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
3 van Amerom JF, Vidarsson L, Wu S, Tessler R, Yoo SJ, Belik J, Macgowan CK. Regional pulmonary blood flow: Comparison of dynamic contrast-enhanced MR perfusion and phase-contrast MR. Magn Reson Med 2009;61:1249-54. [PMID: 19253385 DOI: 10.1002/mrm.21940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ley S, Ley-Zaporozhan J. Pulmonary perfusion imaging using MRI: clinical application. Insights Imaging 2012;3:61-71. [PMID: 22695999 DOI: 10.1007/s13244-011-0140-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kirby M, van Beek EJR, Seo JB, Biederer J, Nakano Y, Coxson HO, Parraga G. Management of COPD: Is there a role for quantitative imaging? Eur J Radiol 2017;86:335-42. [PMID: 27592252 DOI: 10.1016/j.ejrad.2016.08.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Nyilas S, Bauman G, Sommer G. [Assessment of lung impairment in patients with cystic fibrosis : Novel magnetic resonance imaging methods]. Radiologe 2020;60:823-30. [PMID: 32776240 DOI: 10.1007/s00117-020-00730-1] [Reference Citation Analysis]
7 Attenberger UI, Ingrisch M, Büsing K, Reiser M, Schoenberg SO, Fink C. [Magnetic resonance imaging of pulmonary perfusion. Technical requirements and diagnostic impact]. Radiologe 2009;49:739-47. [PMID: 19626308 DOI: 10.1007/s00117-009-1880-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ter-Karapetyan A, Triphan SMF, Jobst BJ, Anjorin AF, Ley-Zaporozhan J, Ley S, Sedlaczek O, Biederer J, Kauczor HU, Jakob PM, Wielpütz MO. Towards quantitative perfusion MRI of the lung in COPD: The problem of short-term repeatability. PLoS One 2018;13:e0208587. [PMID: 30532179 DOI: 10.1371/journal.pone.0208587] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Niedermayer S, Sourbron S, Prompona M, Cyran C, Reiser M, Huber A. Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using a quantitative evaluation. Int J Cardiovasc Imaging 2013;29:1527-36. [DOI: 10.1007/s10554-013-0250-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Mirsadraee S, van Beek EJ. Functional Imaging. Clinics in Chest Medicine 2015;36:349-63. [DOI: 10.1016/j.ccm.2015.02.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Hintze C, Dinkel J, Biederer J, Heussel CP, Puderbach M. [New procedures. Comprehensive staging of lung cancer by MRI]. Radiologe 2010;50:699-705. [PMID: 20628723 DOI: 10.1007/s00117-009-1959-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Ter Voert EE, Heijmen L, Punt CJ, de Wilt JH, van Laarhoven HW, Heerschap A. Reduced respiratory motion artifacts using structural similarity in fast 2D dynamic contrast enhanced MRI of liver lesions. NMR Biomed 2016;29:1526-35. [PMID: 27598946 DOI: 10.1002/nbm.3606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G, Both M, Van Beek EJ, Wild J, Puderbach M. MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging 2012;3:373-86. [PMID: 22695943 DOI: 10.1007/s13244-011-0142-z] [Cited by in Crossref: 98] [Cited by in F6Publishing: 86] [Article Influence: 10.9] [Reference Citation Analysis]
14 Ohno Y, Yoshikawa T, Kishida Y, Seki S, Karabulut N. Unenhanced and Contrast-Enhanced MR Angiography and Perfusion Imaging for Suspected Pulmonary Thromboembolism. AJR Am J Roentgenol 2017;208:517-30. [PMID: 28075625 DOI: 10.2214/AJR.16.17415] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
15 Ley-Zaporozhan J, Molinari F, Risse F, Puderbach M, Schenk JP, Kopp-Schneider A, Kauczor HU, Ley S. Repeatability and reproducibility of quantitative whole-lung perfusion magnetic resonance imaging. J Thorac Imaging 2011;26:230-9. [PMID: 20818278 DOI: 10.1097/RTI.0b013e3181e48c36] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
16 Bauman G, Eichinger M. Ventilation and perfusion magnetic resonance imaging of the lung. Pol J Radiol 2012;77:37-46. [PMID: 22802864 DOI: 10.12659/pjr.882579] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
17 Kim HS, Lee KS, Ohno Y, van Beek EJ, Biederer J. PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer: PET/CT Versus MRI in Lung Cancer. J Magn Reson Imaging 2015;42:247-60. [DOI: 10.1002/jmri.24776] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
18 Sommer G, Bauman G. [MRI methods for pulmonary ventilation and perfusion imaging]. Radiologe 2016;56:106-12. [PMID: 26814473 DOI: 10.1007/s00117-015-0074-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Wielpütz MO, Eichinger M, Puderbach M. Magnetic resonance imaging of cystic fibrosis lung disease. J Thorac Imaging 2013;28:151-9. [PMID: 23545948 DOI: 10.1097/RTI.0b013e31828d40d4] [Cited by in Crossref: 38] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
20 Veldhoen S, Oechsner M, Fischer A, Weng AM, Kunz AS, Bley TA, Köstler H, Ritter CO. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Quantitative Lung Perfusion Imaging Using the Dual-Bolus Approach: Comparison of 3 Contrast Agents and Recommendation of Feasible Doses. Investigative Radiology 2016;51:186-93. [DOI: 10.1097/rli.0000000000000224] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
21 Fujinaga Y, Ueda H, Kitou Y, Tsukahara Y, Sugiyama Y, Kadoya M. Time-intensity curve in the abdominal aorta on dynamic contrast-enhanced MRI with high temporal and spatial resolution: Gd-EOB-DTPA versus Gd-DTPA in vivo. Jpn J Radiol 2013;31:166-71. [PMID: 23179788 DOI: 10.1007/s11604-012-0162-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
22 Hopkins SR, Wielpütz MO, Kauczor HU. Imaging lung perfusion. J Appl Physiol (1985) 2012;113:328-39. [PMID: 22604884 DOI: 10.1152/japplphysiol.00320.2012] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
23 Weller A, O'Brien MER, Ahmed M, Popat S, Bhosle J, McDonald F, Yap TA, Du Y, Vlahos I, deSouza NM. Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer. Eur J Cancer 2016;59:65-78. [PMID: 27016624 DOI: 10.1016/j.ejca.2016.02.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
24 Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, Molinari F, Van Beek EJ, Biederer J. MRI of the lung (1/3): methods. Insights Imaging 2012;3:345-53. [PMID: 22695952 DOI: 10.1007/s13244-012-0176-x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 145] [Article Influence: 17.7] [Reference Citation Analysis]
25 Niedermayer S, Prompona M, Cyran CC, Reiser M, Huber A. Dose response of the intravascular contrast agent gadofosveset trisodium in MR perfusion imaging of the myocardium using semiquantitative evaluation: Gadofosveset in Heart Perfusion Imaging. J Magn Reson Imaging 2014;39:203-10. [DOI: 10.1002/jmri.24091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Eichinger M, Heussel CP, Kauczor HU, Tiddens H, Puderbach M. Computed tomography and magnetic resonance imaging in cystic fibrosis lung disease. J Magn Reson Imaging 2010;32:1370-8. [PMID: 21105141 DOI: 10.1002/jmri.22374] [Cited by in Crossref: 50] [Cited by in F6Publishing: 41] [Article Influence: 5.0] [Reference Citation Analysis]